No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Harrison Bay Life Sciences Announces Commercialization Launch

Editor: What To Know

  • market can be a daunting, expensive, and time-consuming enterprise, particularly for companies that may not have an existing presence in the U.
  • This will become increasingly important in the post-COVID-19 era, as more medical facilities will increasingly limit access, and as there continues to be local shortages of available medical experts and technicians.
  • Harrison Bay Life Sciences (HBLS), headquartered in Chattanooga, Tennessee, recently announced the growth of its business that aids medical device companies seeking a commercialization partner who can bring innovative medical products and services to market.

Launching, marketing, and supporting medical devices in the U.S. market can be a daunting, expensive, and time-consuming enterprise, particularly for companies that may not have an existing presence in the U.S.

Harrison Bay Life Sciences (HBLS), headquartered in Chattanooga, Tennessee, recently announced the growth of its business that aids medical device companies seeking a commercialization partner who can bring innovative medical products and services to market.

HBLS’s unique infrastructure and experienced team provide medical device startup companies with everything they need to successfully achieve and maintain profitability throughout a product’s lifecycle. HBLS will guide products through market analysis and market development; clinical trials and FDA approval; market entry and promotion; logistics, delivery, and inventory management; and provide exceptional clinical support.

Companies will be able to leverage HBLS’ existing relationships and credentials with hospitals, outpatient surgery centers, group purchasing organizations, and physician practices. They’ll also be able to take advantage of HBLS’ proprietary logistics and fulfillment systems, military-grade cybersecurity protocols and consulting, and remote case/procedure support through advanced remote imaging technologies.

Real-Time Imaging Services & Remote Procedure Support
HBLS’s clients benefit from its remote case/procedure support imaging tool, which allows remote users 360° views of a surgical suite as if they were present. The proprietary software merges and renders simultaneous realities without latency, offering meaningful collaboration around the world. It also features built-in 4D, AR and AI capabilities, including adaptive visualization.

This allows technicians to support sophisticated medical devices and physicians remotely, without the need for travel or physically accessing medical facilities. This will become increasingly important in the post-COVID-19 era, as more medical facilities will increasingly limit access, and as there continues to be local shortages of available medical experts and technicians.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy